IMPEDIMED LIMITED — Director's Dealing 2014

Dec 18, 2014

==> picture [99 x 85] intentionally omitted <==

19 December 2014

FOR IMMEDIATE RELEASE

The Manager Company Announcements Office ASX Limited Level 4, Exchange Centre 20 Bridge Street SYDNEY NSW 2000

Correction of exercise restrictions attaching to certain share options granted to the CEO and other key management personnel

ImpediMed Limited (ABN 65 089 705 144) (ASX: IPD) has become aware of an error in the description of the exercise restrictions attaching to certain share options issued to Mr Richard Carreon and other key management personnel, including the description on page 14 through 17 in the Director’s Report of the 2014 Annual Report.

As previously disclosed to ASX, the Board issued 418,100 share options to Mr Carreon and 3,518,200 share options to other key management personnel in 2013, as part of the ESOP at an exercise price of $0.11-0.18 each. The right to exercise these options is also subject to ImpediMed’s ordinary shares achieving a trading price on ASX above $0.50 per share.

It was incorrectly stated that ImpediMed’s share price must be trading on ASX above the specified hurdle price at the time Mr Carreon exercises these options. Mr Carreon may exercise the options at any time after the trading price of ImpediMed’s ordinary shares first exceeds the relevant hurdle price, provided any other applicable exercise conditions have been satisfied. As ImpediMed’s ordinary shares have traded on ASX at a price above $0.50 per share, the $0.50 hurdle price restriction has been satisfied and therefore no longer applies to these options.

-ENDS-

For further details contact:

Steve Denaro

Company Secretary ImpediMed Limited T: +61 7 3860 3700

ImpediMed Limited ABN 65 089 705 144

Unit 1, 50 Parker Court, Pinkenba, QLD 4008 Australia • Tel +61 (7) 3860-3700 Fax +61 (7) 3260-1225 www.impedimed.com